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Abstract 
BACKGROUND: The use of medicinal plants is increasing in several decades for relief many diseases. Indonesia 
consists of thousands of islands with various plants and the manners of the community using plants as a 
treatment for every disease traditionally.  
AIM: Cytotoxic activity of ethyl acetate fraction (EAF) of Zanthoxylum acanthopodium fruit was tested towards 
T47D breast cancer cells.  
METHODS: The in vitro cytotoxic activity was performed by MTT assay, and the result was expressed as the 
IC50 (Inhibitory Concentration), and cell cycle inhibition was investigated by flow cytometry to assess the 
inhibition in every phase of cell cycle, and the role of expression cyclin D1 and p53 in cell cycle inhibition were 
performed by immunocytochemistry.  
RESULTS: EAF was showed to have high activity with a value of IC50 48.94 ± 0.32 µg/mL. EAF of 25 µg/mL 
caused cell accumulation at G0/G1 (60.48%) and in a control cell (51.69%) and decreased expression of cyclin 
D1 and increased expression of p53.  
CONCLUSION: The results obtained in this study provided scientific support for further investigation on 
compounds in Z. acanthopodium fruit which in the future could be used for medication. 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
The world health organisation (WHO) 
reported that breast cancer is one of the leading 
causes of death and the most common cancer type 
amongst women worldwide in 2012 [1]. Moreover, 
breast cancer ranks as the fifth cause of death from 
cancer overall (522,000 deaths), is the most frequent 
cause of cancer death in women in less developed 
countries (324,000 deaths, 14.3% of total), and the 
second cause of cancer death in developed countries 
(198,000 deaths, 15.4%) after lung cancer [2]. The 
diversity of medicinal plants in Indonesia is one of the 
chances in the potential development of Indonesia in 
the globalisation era [3], [4]. The use of medicinal 
plant extracts for the treatment of human disease is 
an ancient practice and thus has greatly increased in 
recent years.  
Traditionally, andaliman fruits (Zanthoxylum 
acanthopodium DC.) has been used as aromaticum 
substances, tonicum, and treat dysentery. Indian 
people have used andaliman to treat paralyzed and 
skin diseases such as abscess and leprosy. 
Andaliman has been used as spices at North 
Sumatera especially at North Tapanuli [5], [6], [7]. The 
plants from Zanthoxylum genus contain many 
compounds such as phenol hydroquinones, 
flavonoids, steroids/ triterpenoids, tannins, glycosides, 
volatile oils, alkaloids, coumarines, lignans, amides 
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and terpenes [8], [9], [10], [11], [12], [13], [14], [15]. 
Ethyl acetate extract of andaliman fruits (EEA) was 
showed to have cytotoxicity effect against MCF-7 and 
T47D cell lines. EEA was found to have a synergistic 
effect when combined with doxorubicin. EEA was 
showed to have anticancer activity towards mice 
induced with benzo(a)pyrene, having a 
cardioprotective effect and active on T47D resistance 
cells [16], [17], [18]. 
This study was aimed to determine cytotoxic 
activity and cell cycle inhibition activity of ethyl acetate 
fraction of Zanthoxylum acanthopodium DC. fruits on 
T47D cells. 
 
 
Material and Methods 
 
Plant and Chemicals  
Fresh fruits of Zanthoxylum acanthopodium 
DC. was collected from Onan Rungu village, Samosir 
regency, Sumatera Utara Province, Indonesia. 
Zanthoxylum acanthopodium DC. was identified in 
Research Centre for Biology, Indonesian Institute of 
Science, Bogor, and the voucher specimen was 
deposited in herbarium with a number of 
332/IPH.1.01/If.07/II/2016, DMSO (Merck), [3-(4,5-
dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium 
bromide] (MTT) (Sigma), propidium iodide kit 
(Biolegend), chromogen 3,3-diaminobenzidin (DAB) 
(Novo Castra), monoclonal antibody cyclin D1 and 
p53 (Abcam). 
 
Preparation of ethyl acetate fraction (EAF) 
The air-dried and powdered fruits 
of Zanthoxylum acanthopodium DC. (1 kg) were 
repeatedly extracted by cold maceration with n-
hexane (3 x 3 d, 7.5 L). The powder was dried in the 
air and extracted with ethyl acetate (3 x 3 d, 7.5 L) at 
room temperature on a shake. The filtrate was 
collected and then evaporated under reduced 
pressure to give a viscous extract and then freeze-
dried to give a dried extract [4], [17], [18], [19]. 
 
Cytotoxicity assay 
EAF was submitted for cytotoxicity test. In that 
way, T47D cell line was grown in RPMI 1640 medium 
containing 10% FetaL Bovine Serum (Gibco), 1% 
penicillin-streptomycin (Gibco), and fungizone 0.5% 
(Gibco) in a flask in a humidified atmosphere (5% 
CO2) at 37°C. The inoculums seeded at 1 x 
10
4
 cells/mL at an optimal volume of 0.1 mL per well. 
After 24 h incubation, the medium was discharged 
and treated by EAF. After incubation for 24 h, the cells 
were incubated with 0.5 mg/mL MTT for 4 h at 37°C. 
Viable cells reacted with MTT to produce purple 
formazan crystals. After 4 h, SDS 10% as a stopper 
(Sigma) in 0.01N HCl (Merck) was added to dissolve 
the formazan crystals. The cells were incubated for 24 
h in room temperature and protected from light. After 
incubation, the cells were shaken, and absorbance 
was measured using ELISA reader at λ 595 nm. The 
data which were absorbed from each well were 
converted to the percentage of viable cells [19] [20], 
[21]. The equation to determine the viability of cells: 
          
  
                             
                                 
        
 
Cell cycle inhibition assay 
T47D cells (1 x 10
6
 cells/well) were seeded 
into 6-well plate and incubated for 24 h. After that, the 
cells were treated with EAF and then incubated for 24 
h. Both floating and adherent cells were collected in a 
conical tube using trypsin 0.025%. The cells were 
washed thrice with cold PBS and centrifuged at 2500 
rpm for 5 min. The supernatant was separated, while 
the sediment was collected and fixed in cold 70% 
ethanol in PBS at 4°C for 1 h. The cells were washed 
thrice with cold PBS and resuspended then 
centrifuged at 3000 rpm for 3 min, and PI kit 
(containing PI 40 µg/mL and RNAse 100 µg/mL) 
added to sediment and resuspended and incubated at 
37°C for 30 min. The samples were analysed using 
FACScan flow cytometer. Based on DNA content, the 
percentage of cells in each of stage in the cell cycle 
(G1, S and G2/M) were calculated using ModFit Lt. 
3.0.s [4], [17], [22].  
 
Immunocytochemistry  
T47D cells (1 x 10
5
 cells/well) were seeded on 
coverslips in 24-well plate and incubated for 24 h. 
After that, the cells were treated with EAF and then 
incubated for 24 h. After incubation, the cells were 
washed with PBS and then fixed with cold methanol at 
4°C for 10 min then the cells were washed with PBS 
and blocked in hydrogen peroxide blocking solution 
for 10 min at room temperature, incubated using 
primary antibody cyclin D1 and p53 for 1 h, then 
washed thrice with PBS, then incubated with 
secondary antibody for 10 min. The cells were 
washed with PBS, then incubated in 3,3-
diaminobenzidine (DAB) solution for 10 min, and 
washed with distilled water. Afterwards, the cells were 
counterstained with Mayer-Haematoxylin for 5 min, 
and the coverslips were taken and washed with 
distilled water, and then immersed with xylol and 
ethanol 70% [4], [22], [23]. 
 
Statistical analysis 
All data were analysed with regression 
analysis using SPSS 22. 
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Results 
 
Cytotoxicity Effect of EAF 
EAF was investigated for its cytotoxicity effect 
on T47D cell lines. The IC50 value of EAF was 48.94 ± 
0.32 µg/mL. MTT method was used to determine cell 
viability after incubation for 24 h. In the treatment was 
showed the inhibition of cells growth.  
 
Cell Cycle Arrest Activity 
To investigate the effect of EAF on gained cell 
death by modulating cell cycle, we concentrated on it 
for further studies using flowcytometry method. The 
effect of EAF is given in Figure 1. Whereas, a single 
treatment with EAF on 25 µg/mL caused cell 
accumulation at G0/G1 (60.48%) and in control cells 
(51.69%). This fact was to indicate that EAF can 
inhibit cell grow at G0/G1 phase. In the cell cycle 
analysis, EAF was exhibited higher G0-G1 phase 
accumulation compared to control cells.  
 
Figure 1: Cell cycle analysis using flow cytometry. T47D cells were 
treated by EAF for 24h and stained using propidium iodide; A) 
control cells; B) EAF 25 µg/mL 
 
In the cell cycle analysis, EAF was exhibited 
higher G0-G1 phase accumulation compared to 
control. This analysis also showed cells underwent 
apoptosis, indicated by the occurrence of apoptosis 
during inhibition of cell cycle on the G0-G1 phase.  
 
Cyclin D1 and p53 Expressions 
Cyclin D1 and p53 (tumour suppressor gen) 
are proteins which play an important role in cell cycles 
process. In the study, the effect of EAF on cyclin D1 
and p53 expressions were evaluated using 
immunocytochemistry.  
 
Figure 2: Expression of cyclin D1 on T47D cells using 
immunocytochemistry; A) control cells; B) EAF 25 µg/mL 
 
Expression of cyclin D1 and p53 protein is 
positively characterised by brown stained nuclei in the 
cells (Figure 2 and Figure 3). In untreated cells 
(negative control) high intensity for cyclin D1 and low 
intensity for p53 was found. A single treatment of EAF 
was decreased on cyclin D1 and increased p53 
expression. 
Cells which express cyclin D1  Cells which 
not express cyclin D1. Inhibition of cyclin D1 protein 
expression strengthened the mechanism of 
modulating cell cycle especially in inhibition of cell 
cycle on the G0-G1 phase.  
 
Figure 3: Expression of p53 on T47D cells using 
immunocytochemistry; A) control cells (Cells which express p53); B) 
EAF 25 µg/mL (Cells which not express p53) 
 
 
Discussion 
 
This research was aimed to investigate the 
efficacy of EAF in cell cycle inhibition. The cytotoxicity 
estimate of the natural product is related to the 
content of active compounds in these plants including 
Zanthoxylum acanthopodium DC. Flavonoids, 
alkaloids, saponins and tannins estimated as active 
compounds [17], [24]. 
This analysis also showed that cells 
underwent apoptosis, indicated by occurrence of 
apoptosis during inhibition of cell cycle on the G0-G1 
phase [4]. Flavonoids and alkaloids could inhibit cell 
cycle progression [25], [26]. 
Cyclin D1 is a cyclin that role in G0-G1 phase 
with established complex with CDK-4 or CDK-6 to 
controlled G1 to S phase transition [27]. Inhibition of 
cell cycle with combination EAE with doxorubicin 
reduced level of cyclin D1 which resulted in inhibition 
of pRb phosphorylation so that E2F can not apart from 
pRb and cells can not transcribe genes that needed in 
cell cycle process or cell proliferation [28], [29]. 
p53 plays an important function in the 
restriction of proliferation in abnormal cells. 
Functioning as a transcription factor p53 up-regulates 
expression of genes which contain a p53 binding 
element whose products contribute to cell cycle arrest 
[30], [31]. Activation of p53 can cause cell cycle arrest 
in different phases. In the majority of cases delay of 
G1/S transition was previously observed [32]. The 
main key in p53 induced cell cycle arrest is played by 
p21
waf1
 which binds to and inhibits a number of cyclin 
and Cdk (Cyclin-dependent kinase) complexes: cyclin 
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D1 – CDK4, cyclin E – CDK2, cyclin A – CDK2, and 
cyclin B – Cdc2 [30], [31], [32].  
However, the molecular mechanism of cell 
cycle modulation by this EAF needs to be explored in 
more detail. Based on the results, it can be concluded 
that ethyl acetate fraction of Zanthoxylum 
acanthopodium DC. fruits have cytotoxicity activity 
through cell cycle arrest, decreases cyclin D1 and 
increase p53 protein expression. The extract is 
potential to be developed as a chemotherapeutic 
agent for breast cancer therapy. 
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